994 resultados para 371.899[82]
Resumo:
Australian climate is highly suitable for using outdoor air for free building cooling. In order to evaluate the suitability of hybrid cooler for specific applications, a pre-design climate assessment tool is developed and presented in this paper. In addition to the consideration of the local climate, comfort zone proposed by ASHRAE handbook and specific design of building and operation of hybrid cooler, possible influence from environmental factors (e.g. air humidity and air velocity), as well as personal factors (e.g. activity level and clothing insulation) on occupant’s thermal comfort are also considered in this tool. It is demonstrated that with the input of climatic data for a particular location and the associated design data for a specific application, the developed climate assessment tool is able to not only sort outdoor air conditions into the different process regions but also project them onto the psychrometric chart. It can also be used to estimate the hours for an individual operational mode under various climate conditions and summarize them in a table “Results”.
Resumo:
The binding of xylo-oligosaccharides to Chainia endoxylanase resulted in a decrease in fluorescence intensity of the enzyme with the formation of 1:1 complex. Equilibrium and thermodynamic parameters of ligand binding were determined by fluorescence titrations and titration calorimetry. The affinity of xylanase for the oligosaccharides increases in the order X-2 < X-3 < X-4 less than or equal to X-5. Contributions from the enthalpy towards the free energy change decreased with increasing chain length from X-2 to X-4, whereas an increase in entropy was observed, the change in enthalpy and entropy of binding being compensatory. The entropically driven binding process suggested that hydrophobic interactions as well as hydrogen bonds play a predominant role in ligand binding.
Resumo:
Objective To quantify and compare the treatment effect and risk of bias of trials reporting biomarkers or intermediate outcomes (surrogate outcomes) versus trials using final patient relevant primary outcomes. Design Meta-epidemiological study. Data sources All randomised clinical trials published in 2005 and 2006 in six high impact medical journals: Annals of Internal Medicine, BMJ, Journal of the American Medical Association, Lancet, New England Journal of Medicine, and PLoS Medicine. Study selection Two independent reviewers selected trials. Data extraction Trial characteristics, risk of bias, and outcomes were recorded according to a predefined form. Two reviewers independently checked data extraction. The ratio of odds ratios was used to quantify the degree of difference in treatment effects between the trials using surrogate outcomes and those using patient relevant outcomes, also adjusted for trial characteristics. A ratio of odds ratios >1.0 implies that trials with surrogate outcomes report larger intervention effects than trials with patient relevant outcomes. Results 84 trials using surrogate outcomes and 101 using patient relevant outcomes were considered for analyses. Study characteristics of trials using surrogate outcomes and those using patient relevant outcomes were well balanced, except for median sample size (371 v 741) and single centre status (23% v 9%). Their risk of bias did not differ. Primary analysis showed trials reporting surrogate endpoints to have larger treatment effects (odds ratio 0.51, 95% confidence interval 0.42 to 0.60) than trials reporting patient relevant outcomes (0.76, 0.70 to 0.82), with an unadjusted ratio of odds ratios of 1.47 (1.07 to 2.01) and adjusted ratio of odds ratios of 1.46 (1.05 to 2.04). This result was consistent across sensitivity and secondary analyses. Conclusions Trials reporting surrogate primary outcomes are more likely to report larger treatment effects than trials reporting final patient relevant primary outcomes. This finding was not explained by differences in the risk of bias or characteristics of the two groups of trials.
Resumo:
Novel species of fungi described in the present study include the following from Australia: Neoseptorioides eucalypti gen. & sp. nov. from Eucalyptus radiata leaves, Phytophthora gondwanensis from soil, Diaporthe tulliensis from rotted stem ends of Theobroma cacao fruit, Diaporthe vawdreyi from fruit rot of Psidium guajava, Magnaporthiopsis agrostidis from rotted roots of Agrostis stolonifera and Semifissispora natalis from Eucalyptus leaf litter. Furthermore, Neopestalotiopsis egyptiaca is described from Mangifera indica leaves (Egypt), Roussoella mexicana from Coffea arabica leaves (Mexico), Calonectria monticola from soil (Thailand), Hygrocybe jackmanii from littoral sand dunes (Canada), Lindgomyces madisonensis from submerged decorticated wood (USA), Neofabraea brasiliensis from Malus domestica (Brazil), Geastrum diosiae from litter (Argentina), Ganoderma wiiroense on angiosperms (Ghana), Arthrinium gutiae from the gut of a grasshopper (India), Pyrenochaeta telephoni from the screen of a mobile phone (India) and Xenoleptographium phialoconidium gen. & sp. nov. on exposed xylem tissues of Gmelina arborea (Indonesia). Several novelties are introduced from Spain, namely Psathyrella complutensis on loamy soil, Chlorophyllum lusitanicum on nitrified grasslands (incl. Chlorophyllum arizonicum comb. nov.), Aspergillus citocrescens from cave sediment and Lotinia verna gen. & sp. nov. from muddy soil. Novel foliicolous taxa from South Africa include Phyllosticta carissicola from Carissa macrocarpa, Pseudopyricularia hagahagae from Cyperaceae and Zeloasperisporium searsiae from Searsia chirindensis. Furthermore, Neophaeococcomyces is introduced as a novel genus, with two new combinations, N. aloes and N. catenatus. Several foliicolous novelties are recorded from La Réunion, France, namely Ochroconis pandanicola from Pandanus utilis, Neosulcatispora agaves gen. & sp. nov. from Agave vera-cruz, Pilidium eucalyptorum from Eucalyptus robusta, Strelitziana syzygii from Syzygium jambos (incl. Strelitzianaceae fam. nov.) and Pseudobeltrania ocoteae from Ocotea obtusata (Beltraniaceae emend.). Morphological and culture characteristics along with ITS DNA barcodes are provided for all taxa.
Resumo:
Atrial fibrillation is the most common arrhythmia requiring treatment. This Thesis investigated atrial fibrillation (AF) with a specific emphasis on atrial remodeling which was analysed from epidemiological, clinical and magnetocardiographic (MCG) perspectives. In the first study we evaluated in real-life clinical practice a population-based cohort of AF patients referred for their first elective cardioversion (CV). 183 consecutive patients were included of whom in 153 (84%) sinus rhythm (SR) was restored. Only 39 (25%) of those maintained SR for one year. Shorter duration of AF and the use of sotalol were the only characteristics associated with better restoration and maintenance of SR. During the one-year follow-up 40% of the patients ended up in permanent AF. Female gender and older age were associated with the acceptance of permanent AF. The LIFE-trial was a prospective, randomised, double-blinded study that evaluated losartan and atenolol in patients with hypertension and left ventricular hypertrophy (LVH). Of the 8,851 patients with SR at baseline and without a history of AF 371 patients developed new-onset AF during the study. Patients with new-onset AF had an increased risk of cardiac events, stroke, and increased rate of hospitalisation for heart failure. Younger age, female gender, lower systolic blood pressure, lesser LVH in ECG and randomisation to losartan therapy were independently associated with lower frequency of new-onset AF. The impact of AF on morbidity and mortality was evaluated in a post-hoc analysis of the OPTIMAAL trial that compared losartan with captopril in patients with acute myocardial infarction (AMI) and evidence of LV dysfunction. Of the 5,477 randomised patients 655 had AF at baseline, and 345 patients developed new AF during the follow-up period, median 3.0 years. Older patients and patients with signs of more serious heart disease had and developed AF more often. Patients with AF at baseline had an increased risk of mortality (hazard ratio (HR) of 1.32) and stroke (HR 1.77). New-onset AF was associated with increased mortality (HR 1.82) and stroke (HR of 2.29). In the fourth study we assessed the reproducibility of our MCG method. This method was used in the fifth study where 26 patients with persistent AF had immediately after the CV longer P-wave duration and higher energy of the last portion of atrial signal (RMS40) in MCG, increased P-wave dispersion in SAECG and decreased pump function of the atria as well as enlarged atrial diameter in echocardiography compared to age- and disease-matched controls. After one month in SR, P-wave duration in MCG still remained longer and left atrial (LA) diameter greater compared to the controls, while the other measurements had returned to the same level as in the control group. In conclusion is not a rare condition in either general population or patients with hypertension or AMI, and it is associated with increased risk of morbidity and mortality. Therefore, atrial remodeling that increases the likelihood of AF and also seems to be relatively stable has to be identified and prevented. MCG was found to be an encouraging new method to study electrical atrial remodeling and reverse remodeling. RAAS-suppressing medications appear to be the most promising method to prevent atrial remodeling and AF.
Resumo:
We report interesting anomalies in the temperature dependent Raman spectra of FeSe0.82 measured from 3 K to 300 K in the spectral range from 60 to 1800 cm(-1) and determine their origin using complementary first-principles density functional calculations. A phonon mode near 100 cm-1 exhibits a sharp increase by similar to 5% in the frequency below a temperature T-s (similar to 100 K) attributed to strong spin-phonon coupling and onset of short-range antiferromagnetic order. In addition, two high frequency modes are observed at 1350 cm-1 and 1600 cm-1, attributed to electronic Raman scattering from (x(2)-y(2)) to xz/yz d-orbitals of Fe. (C) 2010 Elsevier Ltd. All rights reserved.
Resumo:
Stroke is a major cause of death and disability, incurs significant costs to healthcare systems, and inflicts severe burden to the whole society. Stroke care in Finland has been described in several population-based studies between 1967 and 1998, but not since. In the PERFECT Stroke study presented here, a system for monitoring the Performance, Effectiveness, and Costs of Treatment episodes in Stroke was developed in Finland. Existing nationwide administrative registries were linked at individual patient level with personal identification numbers to depict whole episodes of care, from acute stroke, through rehabilitation, until the patients went home, were admitted to permanent institutional care, or died. For comparisons in time and between providers, patient case-mix was adjusted for. The PERFECT Stroke database includes 104 899 first-ever stroke patients over the years 1999 to 2008, of whom 79% had ischemic stroke (IS), 14% intracerebral hemorrhage (ICH), and 7% subarachnoid hemorrhage (SAH). A 18% decrease in the age and sex adjusted incidence of stroke was observed over the study period, 1.8% improvement annually. All-cause 1-year case-fatality rate improved from 28.6% to 24.6%, or 0.5% annually. The expected median lifetime after stroke increased by 2 years for IS patients, to 7 years and 7 months, and by 1 year for ICH patients, to 4 years 5 months. No change could be seen in median SAH patient survival, >10 years. Stroke prevalence was 82 000, 1.5% of total population of Finland, in 2008. Modern stroke center care was shown to be associated with a decrease in both death and risk of institutional care of stroke patients. Number needed to treat to prevent these poor outcomes at one year from stroke was 32 (95% confidence intervals 26 to 42). Despite improvements over the study period, more than a third of Finnish stroke patients did not have access to stroke center care. The mean first-year healthcare cost of a stroke patient was ~20 000 , and among survivors ~10 000 annually thereafter. Only part of this cost was incurred by stroke, as the same patients cost ~5000 over the year prior to stroke. Total lifetime costs after first-ever stroke were ~85 000 . A total of 1.1 Billion , 7% of all healthcare expenditure, is used in the treatment of stroke patients annually. Despite a rapidly aging population, the number of new stroke patients is decreasing, and the patients are more likely to survive. This is explained in part by stroke center care, which is effective, and should be made available for all stroke patients. It is possible, in a suitable setting with high-quality administrative registries and a common identifier, to avoid the huge workload and associated costs of setting up a conventional stroke registry, and still acquire a fairly comprehensive dataset on stroke care and outcome.
Resumo:
El presente estudio se realizó en la Estación Experimental " Raúl González" del Valle de Sebaco en el período del 5 de junio al 16 de septiembre de 1992. Se evaluaron las variedades, UC-82 y Topacio, las densidades de siembra de 27,777 y 50,000 plantas/ha y cuatro niveles de nitrógeno, O Kg/ha, 75 Kg/ha, 150 Kg/ha y 225 Kg/ha. Se desarrolló el estudio con tres factores y se estableció un diseño de Bloques Completos al Azar, evaluándose los parámetros de crecimiento del cultivo, así como, lo relacionado al rendimiento agronómico e industrial. Los datos obtenidos se sometieron al análisis de varianza y a la prueba de SNK al 5%, Los resultados en cuanto a crecimiento y desarrollo fueron los siguientes: La mayor altura la presentó la variedad UC-82 en combinación con la densidad de 50,OOO plantas/ha y con la aplicación de 75 Kg/ha de Nitrógeno; e1 mayor número de hijos se obtuvo con la misma variedad y densidad y la aplicación de 225 Kg/ha de Nitrógeno. En cuanto a floración y fructificación los mejores resultados se alcanzaron con la variedad UC-82, la densidad de 27,111 plantas/ha y con 75 Kg/ha de Nitrógeno. Respecto al rendimiento agronómico, el mejor tratamiento fue la variedad uc-82, con la densidad de 50,000 plantas/ha y una aplicación de 75 Kg/ha de Nitrógeno. En el rendimiento industrial la variedad Topacio, con la densidad de 50,000 plantas/ha y 225 Kg/ha de Nitrógeno reporta los mejores resultados.
Resumo:
El trabajo se realizó de Octubre de 1996 a Marzo de 1997, en la Estación Experimental "Raúl González" del valle de Sébaco, Matagalpa. Se evaluó la utilización de "Microorganismos Efectivos" en el manejo de insectos-plagas y enfermedades en el cultivo del tomate (Lycopersicum esculentum Mili), variedad UC-82. Los tratamientos utilizados fueron: Tratamiento 1, Productos Químicos; Tratamiento 2, Neem (Azadirachta indica); Tratamiento 3, EM-5B (extracto de hierbas y microorganismos); Tratamiento 4, EM-5 (microorganismos); Tratamiento 5, Testigo absoluto (sin ningún tipo de aplicación). En la etapa de semillero los tratamientos EM-5 y EM-5B mostraron un efecto reductor sobre las poblaciones de mosca blanca (Bemisia tabaci Genn). Después del trasplante la mayor densidad de mosca blanca se observó en el tratamiento a base de productos químicos. El mayor porcentaje de poblaciones de Lyriomiza spp. lo obtuvieron los tratamientos químicos y EM-5. En cuanto al porcentaje de población de Diabrotica spp. no se presentaron diferencias significativas a lo largo del experimento. Referente al daño causado por Heliothis spp. se observó a los 77 DDT (días después del trasplante), los tratamientos en los que menos daños se presentaron fueron neem y químico. Sin embargo estos mismos tratamientos mostraron mayor incidencia de virosis a los 42 DDT, asi mismo no se observó diferencias estadísticas. La mayor altura la presentó el tratamiento EM-5B y el mayor número de hijos lo obtuvo el tratamiento químico y EM-5. También se presentaron resultados positivos entre los caracteres grosor del mesocarpio y diámetro polar y ecuatorial obteniendo los mejores resultados EM- 5 y EM-5B. En cuanto al rendimiento comercial de producción el tratamiento que dio valores más aceptables fue el de Neem con 26,974 Kg/Ha de frutos comercializables con rendimiento total 27,979 Kg/Ha; haciendo la salvedad que este tratamiento fue fertilizado con el biofertilizante EM-Bokashi
Resumo:
El ensayo se realizó a partir de Diciembre de 1989 hasta Abril de 1990, en la Cooperativa "Rubén Duarte", Managua, con el obJetivo de "Determinar la influencia de diferentes cultivos antecesores y métodos de control de malezas sobre el crecimiento. desarrollo y rendimiento en el cultivo del tomate". El experimente se estableció en un diseño de Bloques Completos al azar en parcelas divididas con cuatro repeticiones por tratamientos en estudio. Los resultados indican que la mayor abundancia total de malezas se presentó cuando el cultivo antecesor fue el fríjol, reportandose la menor abundancia total en el control mecánico. El mayor peso seco total de malezas se presentó cuando antecedió el cultivo del frijol siendo mayores en las Poáceas y Dicotiledóneas, en el control con Metribuzin fueron las Poáceas y en el control con FluazHop las Dicotiledóneas. En cuanto a la diversidad se reportó que para ambos cultivos antecesores existió alta diversidad, los métodos de control reportaron alta diversidad al comienzo del ciclo disminuyendo al final del ciclo a excepción del control con FluazHop el cual presentó igual diversidad tanto al inicio como al final del ciclo. Con respecto al comportamiento general de las variables de crecimiento y componentes del rendimiento podemos decir que fue similar, presentando llgeramente diferencias la rotación del frijol - tomate y el control mecánico con azadon.